Macroaxis considers Virtus LifeSci to be not too volatile. Virtus LifeSci Biotech
owns Efficiency Ratio (i.e. Sharpe Ratio) of -0.0941 which indicates Virtus LifeSci Biotech
had -0.0941% of return per unit of risk over the last 2 months. Macroaxis philosophy towards measuring risk of any etf is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators
. Virtus LifeSci Biotech Clinical Trls ETF exposes twenty-one different technical indicators
which can help you to evaluate volatility that cannot be diversified away. Please be advised to validate Virtus LifeSci Coefficient Of Variation
of 1,580 and Risk Adjusted Performance of 0.10 to confirm risk estimate we provide. The entity has beta of 0.3317 which indicates as returns on market increase, Virtus LifeSci returns are expected to increase less than the market. However during bear market, the loss on holding Virtus LifeSci will be expected to be smaller as well.. Even though it is essential to pay attention to Virtus LifeSci Biotech current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Virtus LifeSci Biotech Clinical Trls ETF exposes twenty-one different technical indicators which can help you to evaluate its performance.
|15 days auto-correlation||(0.30) |
Weak reverse predictability
Virtus LifeSci Biotech Clinical Trls ETF has weak reverse predictability. Overlapping area represents the amount of predictability between Virtus LifeSci time series from February 24, 2018 to March 26, 2018 and March 26, 2018 to April 25, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Virtus LifeSci Biotech price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Virtus LifeSci price fluctuation can be explain by its past prices. Given that Virtus LifeSci Biotech Clinical Trls ETF has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Virtus LifeSci for similar time interval.
|Correlation Coefficient|| -0.3|
|Spearman Rank Test|| -0.13|
|Price Variance|| 1.05|
|Lagged Price Variance|| 0.57|